{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:25:21Z","timestamp":1793816721679,"version":"4.6.1"},"reference-count":35,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T00:00:00Z","timestamp":1539820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Viral Hepatitis"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Nucleos(t)ide analogues (<jats:styled-content style=\"fixed-case\">NA<\/jats:styled-content>) are effective in suppressing hepatitis B virus (<jats:styled-content style=\"fixed-case\">HBV<\/jats:styled-content>) replication, but most patients require long\u2010term treatment. This study aimed to investigate switching to peginterferon as a strategy to stop <jats:styled-content style=\"fixed-case\">NA<\/jats:styled-content>. Hepatitis B e antigen (<jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>eAg)\u2010positive chronic hepatitis B patients who developed <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>eAg seroconversion during <jats:styled-content style=\"fixed-case\">NA<\/jats:styled-content> treatment were studied. All patients received open\u2010label peginterferon alfa\u20102a 180\u00a0\u03bcg\/wk for 48\u00a0weeks, and <jats:styled-content style=\"fixed-case\">NA<\/jats:styled-content> was stopped at week 4 of peginterferon treatment. The primary endpoint was sustained response, which was defined as negative <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>eAg, positive anti\u2010<jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>e and <jats:styled-content style=\"fixed-case\">HBV DNA<\/jats:styled-content> &lt;2000\u00a0IU\/mL at week 72. Other secondary endpoints including <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg loss at week 72 were also studied. Forty\u2010one patients treated with entecavir for 56\u00a0\u00b1\u00a023\u00a0months were recruited. Sustained response was achieved in 30 patients (73%, 95% confidence interval 58%\u201084%). At week 72, 31 (76%) patients had <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>eAg seroconversion, 56 (23%) patients had undetectable <jats:styled-content style=\"fixed-case\">HBV DNA<\/jats:styled-content>, 31 (76%) patients had normal <jats:styled-content style=\"fixed-case\">ALT<\/jats:styled-content>, and 6 patients (15%) had <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg loss. Baseline <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg level was the best predictor for both sustained response and <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg loss; the best <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg cut\u2010off for sustained response was &lt;1500\u00a0IU\/mL and that for HBsAg loss was &lt;500\u00a0IU\/mL by receiver operating characteristic curve analysis. Twenty\u2010two of 25 (88%) patients with baseline HBsAg &lt;1500\u00a0IU\/mL had sustained response. Five of 10 (50%) patients with baseline HBsAg &lt;500\u00a0IU\/mL developed <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg loss. Switching to peginterferon can be considered as a treatment option in <jats:styled-content style=\"fixed-case\">NA<\/jats:styled-content>\u2010treated patients with <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>eAg seroconversion, particularly among those with lower <jats:styled-content style=\"fixed-case\">HB<\/jats:styled-content>sAg levels.<\/jats:p>","DOI":"10.1111\/jvh.13000","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T01:49:29Z","timestamp":1536198569000},"page":"126-135","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Switching to peginterferon for chronic hepatitis B patients with hepatitis B e antigen seroconversion on entecavir \u2013 A prospective study"],"prefix":"10.1111","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7790-1611","authenticated-orcid":false,"given":"Henry L. Y.","family":"Chan","sequence":"first","affiliation":[{"name":"Department of Medicine and Therapeutics and Institute of Digestive Disease The Chinese University of Hong Kong  Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona W. S.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Medicine Kwong Wah Hospital  Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aric J.","family":"Hui","sequence":"additional","affiliation":[{"name":"Department of Medicine Alice Ho Miu Ling Nethersole Hospital  Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K. K.","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medicine Tuen Mun Hospital  Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kam H.","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Medicine North District Hospital  Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace L. H.","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics and Institute of Digestive Disease The Chinese University of Hong Kong  Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching K.","family":"Loo","sequence":"additional","affiliation":[{"name":"Department of Medicine Kwong Wah Hospital  Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel M. L.","family":"Chim","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics and Institute of Digestive Disease The Chinese University of Hong Kong  Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi H.","family":"Tse","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics and Institute of Digestive Disease The Chinese University of Hong Kong  Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent W. S.","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics and Institute of Digestive Disease The Chinese University of Hong Kong  Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,10,18]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.5724"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2008.03816.x"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26301"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.01.002"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27894"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-017-0754-9"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-015-9675-4"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28156"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28438"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23568"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.05.031"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.06.019"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12189"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.05.044"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP3019"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2017.00072"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.10185"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.16665"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50117"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(03)00394-5"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.3.420"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043470"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1466"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu702"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2015.09.043"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60220-8"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802878"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051285"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61425-1"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23327"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.08.009"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.07.012"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.09.018"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.05.008"}],"container-title":["Journal of Viral Hepatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjvh.13000","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvh.13000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T01:57:43Z","timestamp":1694656663000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jvh.13000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,18]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.1111\/jvh.13000"],"URL":"https:\/\/doi.org\/10.1111\/jvh.13000","archive":["Portico"],"relation":{},"ISSN":["1352-0504","1365-2893"],"issn-type":[{"value":"1352-0504","type":"print"},{"value":"1365-2893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,18]]},"assertion":[{"value":"2018-05-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}